The Health Resources & Services Administration has unveiled its formal plans for a revised version of its contentious 340B ...
The Centers for Medicare and Medicaid Services’ recent proposal to overhaul Medicare’s reimbursement rates for 340B drugs will be a drag on many large hospitals and those treating a disproportionat | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results